Xenon Xe-129, Hyperpolarized

CHEMBL4594411 Phase 4 Одобрено Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
128.9 g/mol
LogP
Phase
4

Hyperpolarized xenon-129 is a nuclear spin-polarized form of 129Xe gas used in MRI to provide high-resolution imaging of pulmonary airspaces, airways, and gas exchange based on its unique NMR properties, particularly its sensitivity to the microenvironment of red blood cells and lung tissue. Unlike conventional contrast agents, it enables non-radioactive MRI-based assessment of regional ventilation, diffusion, and gas transfer function in lung diseases including COPD, asthma, and interstitial lung disease. Its hyperpolarized state provides a several-thousand-fold enhancement in MRI signal.

Молекулярная масса

128,9048 g/mol

TPSA

0,00 Ų

Механизм действия

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Механизм

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

2D Структура

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

[129Xe]

InChI

InChI=1S/Xe/i1-2

Molecular Formula

Xe

HBD / HBA

- / -

Вращаемые Связи

0

Тяжёлые Атомы

1

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Часто задаваемые вопросы

Hyperpolarized xenon-129 is a nuclear spin-polarized form of 129Xe gas used in MRI to provide high-resolution imaging of pulmonary airspaces, airways, and gas exchange based on its unique NMR properties, particularly its sensitivity to the microenvironment of red blood cells and lung tissue. Unlike conventional contrast agents, it enables non-radioactive MRI-based assessment of regional ventilation, diffusion, and gas transfer function in lung diseases including COPD, asthma, and interstitial lung disease. Its hyperpolarized state provides a several-thousand-fold enhancement in MRI signal.

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

Yes, Xenon Xe-129, Hyperpolarized is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4594411. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 10290811. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Медицинский отказ от ответственности

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.